Print Page

Medicine recalls

 
Australia: Acetazolamide (Diamox) 250 mg tablets: Recall - potential contamination
 
Consumers and health professionals are advised that Aspen Pharma and Arrow Pharma, in consultation with the TGA, are recalling one batch of acetazolamide 250 mg tablets which is marketed in Australia as Diamox (batch no.: CD485).

Acetazolamide is a medicine used to treat oedema, epilepsy and glaucoma. It has been identified that bottles of acetazolamide tablets from the affected batch may be contaminated with fungus - Penicillium and/or Aspergillus species. Affected tablets may have a dusty, mouldy or abnormal appearance.

Consumers are advised to stop using the affected batch of product, and return it to the pharmacy where it was purchased for a refund or replacement.

Please refer to the following website in TGA for details: http://www.tga.gov.au/alert/acetazolamide-diamox-250-mg-tablets

In Hong Kong, the above product is not a registered pharmaceutical product.


Ends/ Thursday, February 04, 2016
Issued at HKT 13:00
 
 
back